Moussa Mansour, MD
Clinical Cardiac Electrophysiology · Boston, MANPI 1588649560
Payments from drug & device makers
Across 560 payments — averaging $6771.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$1.8M
- Boston Scientific$1.2M
- Medical Device Business Services, Inc.$281K
- Abbott$209K
- Adagio Medical, Inc.$174K
- Medtronic$109K
- plus $66K from 6 others
Across 2 payments — averaging $6777.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biosig Technologies, Inc.$14K
What the payments were for
- Consulting fees$63,17543%
- Speaking & faculty fees$12,7639%
- Grants$1,5001%
- Travel & lodging$54,94338%
- Food & beverage$13,0159%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 131 | $1,802,082 |
| Boston Scientific | 231 | $1,150,628 |
| Medical Device Business Services, Inc. | 60 | $280,538 |
| Abbott | 95 | $208,910 |
| Adagio Medical, Inc. | 6 | $174,389 |
| Medtronic(3 entities) | 23 | $108,817 |
| Kardium Inc. | 5 | $21,000 |
| Volta Medical Inc | 1 | $18,500 |
| Biosig Technologies, Inc. | 1 | $15,000 |
| Baylis Medical Company Inc | 3 | $7,363 |
| Philips North America LLC | 2 | $4,357 |
| Biotronik Inc. | 2 | $236 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$31,525
- Thermocool SF$24,926
- Watchman$10,647
- Carto 3 System$9,084
- Navistar$9,029
- WATCHMAN Access System$6,687
- Ensite Cardiac Mapping System$6,110
- Spectranetics Undiv$4,225
- GENERAL EP$4,000
- NRG needle$3,325
- VersaCross Access Solution$2,375
- GENERAL - THERAPIES$2,119
- Farapulse$1,869
- Reveal LINQ$1,800
- VersaCross$1,663
- TactiCath Quartz CFA Catheter$1,600
- CLINICAL TRIAL PRODUCT$800
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$284
- KYPHON Balloon Kyphoplasty$174
- LINQ II$167
How this compares
$3,791,820 in reported general payments places this provider in the 95th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.
See all clinical cardiac electrophysiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $105,232 |
| Metoprolol Succinate | 52 | $976 |
| Prednisone | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Boston
- Elad AnterBoston$4.5M
- Vassilios BezzeridesBoston$1.3M
- Laurence EpsteinBoston$930K
- Andre DavilaBoston$696K
- Usha TedrowBoston$639K
- Jagmeet SinghBoston$626K
- Patricia TungBoston$487K
- Jonathan WaksBoston$389K
- Andrew LockeBoston$376K
- Gregory MichaudBoston$270K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.